Strikingly, untreated A375s yield HMDMs exhibiting a tumor-associated macrophage phenotype characterized by CD40, CD80, and CD206 surface expression while injured A375s yield HMDMs with markers of increased antigen presentation, namely HLADR and CD86. The gene discussed is CD80; the disease is neoplasm.